489 results on '"Resta, Onofrio"'
Search Results
2. The hospital emigration to another region in the light of the environmental, social and governance model in Italy during the period 2004-2021
3. Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
4. Investigating the Determinants of Beds for High-Care Specialties in the Italian Regions in the Environmental, Social and Governance Model
5. Elderly People Treated in Integrated Home Care in Italian Regions: A Metric Approach
6. The Hospital Emigration to Another Region in the Light of the Environmental, Social and Governance Model in Italy During the Period 2004-2021
7. Investigating the Determinants of Beds for High-Care Specialties in the Italian Regions in the Environmental, Social and Governance Model
8. Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19
9. Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system
10. Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea
11. Low-intensity rehabilitation in persistent post COVID-19 dyspnoea: the value of Spa health resort as appropriate setting.
12. More skilled clinical management of COVID-19 patients modified mortality in an intermediate respiratory intensive care unit in Italy
13. Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
14. Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
15. Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis
16. Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure
17. Significant burden of post-COVID exertional dyspnoea in a South-Italy region: knowledge of risk factors might prevent further critical overload on the healthcare system.
18. Contributors
19. Delusions in dementias
20. A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy
21. Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study
22. Electronic Nose Technology in Respiratory Diseases
23. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation
24. Predictive tools for nocturnal respiratory failure in patients with moderate and severe OSAS
25. Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea
26. Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management
27. The association between dysphagia and OSA
28. An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls
29. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis
30. Is there a correlation between OSAS duration/severity and carotid intima-media thickness?
31. Sleep Related Breathing Disorders in Adults with Down Syndrome.
32. The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea
33. Relationships between Obstructive Sleep Apnea Syndrome and cardiovascular risk in a naïve population of southern Italy
34. Clinical phenotypes and characteristics in patients with OSAS and nocturnal respiratory failure
35. Correlation between nasal inflammation and COVID-19 related pneumonia evaluated by nasal cytology
36. Reduction of Sniff Nasal Inspiratory Pressure (SNIP) as an Early Indicator of the Need of Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis
37. COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy
38. Incidence of deep venous thrombosis in patients with both pulmonary embolism and COPD
39. Prolonged Active Prone Positioning in Spontaneously Breathing Non-intubated Patients With COVID-19-Associated Hypoxemic Acute Respiratory Failure With PaO2/FiO2 >150
40. Effect of CPAP on cardiovascular risks in OSA patients. A 4-year follow-up, preliminary data
41. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD
42. Additional file 1 of Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis
43. Additional file 3 of Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis
44. Obstructive Sleep Apnea Syndrome does not increase the cardiovascular risk in a naïve population of southern Italy
45. Predictive equations for CPAP titration in OSAS patients
46. Titration effectiveness of two autoadjustable continuous positive airway pressure devices driven by different algorithms in patients with obstructive sleep apnoea
47. Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis
48. Bilevel and continuous positive airway pressure and factors linked to all-cause mortality in COVID-19 patients in an intermediate respiratory intensive care unit in Italy
49. Baseline characteristics and outcomes of COVID-19 patients admitted to a Respiratory Intensive Care Unit (RICU) in Southern Italy
50. Author_Response_1 – Supplemental material for Switching from omalizumab to mepolizumab: real-life experience from Southern Italy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.